Keywords
Menopausia
Calidad de vida
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the frequency of use of hormone replacement therapy (HRT) and its effects on symptoms and perception of well-being in climacteric and menopausal women. Methods: Cross-sectional study with 264 women in climacteric and menopause, assessed through an online questionnaire applied between November 2024 and October 2025. Clinical variables, symptoms, type of HRT, and perception of quality of life were included. The significance level adopted was p < 0.05. Results: The mean age was 54 ± 7.17 years, with menopause at 47.4 ± 5.91 years. The most prevalent symptoms were hot flashes (48.8%), insomnia (22.7%), and irritability (17.7%). Only 41.3% used HRT, with transdermal gel (27.5%) and oral administration (22.9%) being the most commonly used forms. Among non-users, the main reason was the absence of a medical prescription (48.3%). Among users, 80% reported good adaptation and 61.1% a significant improvement in quality of life. Conclusion: HRT showed a positive impact on quality of life and control of climacteric symptoms, but it is still underutilized due to fear of risks and medical hesitancy in prescribing.
References
ANAGNOSTIS P, et al. Menopausal hormone therapy and cardiovascular risk: where are we now? Curr Vasc Pharmacol. 2019; 17(6): 564–572.
ANDRADE NGA et al. Impacto da menopausa na saúde mental e física: Uma abordagem multidisciplinar. Brazilian Journal of Implantology and Health Sciences, 2024; 6(8):3042-57.
ARANTES CS, et al. Estudo sobre os sintomas climatéricos em mulheres: uma revisão de literatura. Revista Ft. 2024.Disponível em:https://revistaft.com.br/estudo-sobre-os-sintomas-climatericos-em-mulheres-uma-revisao-de-literatura. Acesso em: novembro 2025.
AVIS NE, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med, 2015; 175(4): 531-9.
BRINTON RD, et al. Estrogen regulation of brain metabolism and implications for Alzheimer’s disease prevention. Nat Rev Endocrinol. 2023; 19(4): 213–230.
CLAPAUCH R, et al. Terapia Hormonal da Menopausa: Posicionamento do Departamento de Endocrinologia Feminina e Andrologia da SBEM em 2004. Arq Bras Endocrinol Metab., 2005; 49 (3): 449-54.
DAVIS SR, et al. The 2023 Practitioner’s Toolkit for Managing Menopause. Climacteric, 2023; 26(6): 517-536.
DIAS GN, PEREIRA LM. Uso do Google Forms em pesquisas clínicas: relato de experiência. Revista Brasileira de Pesquisa Aplicada em Saúde. 2021; 3(2):80–86.
DO CARMO IA, et al. Indicações e contraindicações do uso de terapia de reposição hormonal. Braz J Health Rev, 2023; 6(5): 24279–24286.
FDA. US Food & Drug Administration. FDA News Release HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. 2025. Disponível em: https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy. Acesso em: 10 de novembro 2025.
GLEASON CE, et al. Effects of oral and transdermal estrogen on cognitive function in the KEEPS trial: do type and route of administration matter? JAMA Intern Med. 2016;176(10): 1499-1507.
GREENDALE GA, et al. The Menopause Transition and Cognition. JAMA, 2020; 21; 323(15): 1495-1496.
HARMAN SM, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2014;17(suppl 2): 3-11.
HODIS HN, et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE TRIAL). N Engl J Med., 2016; 374(13): 1221-31.
KIM H, et al. Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study. Alzheimer’s Res Ther, 2022; 16;14(1):83.
LEE SA RA, et al. The 2020 menopausal hormone therapy guidelines.Journal of menopausal medicine, 2020; 26(2): 69-98.
LIMA SMR, et al. Menopausa – O que você precisa saber: abordagem prática e atual do período do climatério. 2. ed. Editora Atheneu. Disponível em: https://www.amazon.com.br/dp/8538805282Acesso em: 05 jun. 2024.
LOUZADA GV, et al. Os efeitos da terapia de reposição hormonal em mulheres na menopausa. Revista Eletrônica Acervo Médico, 2023; 23(1): e11625.
MALTA DC, et al. Cardiovascular Risk Estimates in Ten Years in the Brazilian Population, a Population-Based Study. Arq Bras Cardiol., 2021;116(3): 423-31.
MELO ABO, et al. Terapia de reposição hormonal: benefícios e riscos durante a menopausa. Periódicos Brasil. Pesquisa Científica. 2023; 5(3): 1436-46.
MOTA JS. Google Forms como ferramenta de coleta de dados em pesquisas em saúde: vantagens e limitações. Revista de Metodologias Digitais em Saúde. 2019; 1(1): 45–52.
NORTH AMERICAN MENOPAUSE SOCIETY (NAMS). Position Statement on Menopausal Hormone Therapy. Menopause. 2023. Disponível em: https://www.menopause.org/. Acesso em: 09 jun. 2024.
OLIVEIRA GLL, et al. Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa. Arq. Bras. Cardiol., 2024; 121 (7): 1-75.
ROSSOUW JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-333.
ROSSOUW JE, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1 465-77.
SELBAC MT et al. Mudanças comportamentais e fisiológicas determinadas pelo ciclo biológico feminino: Climatério a menopausa. Aletheia, Periódicos eletrônicos em psicologia. 2018; 51:177-190.
SHUMAKER SA, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20): 2651-62.
SILVA LFA, et al. Idade da menopausa e fatores associados em mulheres brasileiras: revisão narrativa. Revista Eletrônica Acervo Saúde, 2023: 16(2): e16850.
SOUSA JKS, MARTINS LFS, OLIVEIRA JAF. (2024). Avanços na terapia de reposição hormonal na menopausa: eficácia e segurança. Braz J Implantol Health Sci. 6(1): 2234–44.
SOUZA JKS, et al. Avanços na Terapia de Reposição Hormonal na Menopausa: Eficácia e Segurança. Brazilian Journal of Implantology and Health Sciences, 2024; 6(1): 2234-44.
SPRITZER PM, WENDER MCO. Terapia hormonal na menopausa: quando não usar. Arq Bras Endocrinol Metab., 2007; 51 (7): 1058-63.
STUTE P, et al. Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice. Maturitas, 2023; 174: 8-13.
WENDER MCO, et al. E-Book - Coleção Febrasgo - Climatério e Menopausa. 2019. 472p.